Can Insurers Curb Opioid Abuse? CDC Puts Spotlight On Payers
This article was originally published in The Pink Sheet Daily
Executive Summary
As Medicare emerges as the dominant payer for opioids, CDC urges research into how government and private payers could best employ prior authorization and drug utilization reviews.